Presepsin as a predictive biomarker of severity in COVID-19: a case series. Fukada A, Kitagawa Y, Matsuoka M, Sakai J, et al. J Med Virol 2020 Jun 12. doi: 10.1002/jmv.26164.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukada A, Kitagawa Y, Matsuoka M, Sakai J, et al. Presepsin as a predictive biomarker of severity in COVID-19: a case series. J Med Virol 2020 Jun 12. doi: 10.1002/jmv.26164.
PMID: 32530491